Initial Therapeutics is a biotechnology company focused on developing innovative therapies for the treatment of cancer and other serious diseases. They make money by researching, developing, and commercializing novel drug candidates, often partnering with larger pharmaceutical companies for funding and distribution. Founded by leading scientists in the field, the company has a history of leveraging cutting-edge technology to target disease mechanisms at the molecular level, aiming to bring transformative treatments to patients worldwide.